Harvard University licenses its nasal swab collection technology to Rhinostics
The license was coordinated by Harvard's Office of Technology Development (OTD) in accordance with the University's commitment to the COVID-19 Technology Access…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 May 21
The license was coordinated by Harvard's Office of Technology Development (OTD) in accordance with the University's commitment to the COVID-19 Technology Access…
04 May 21
The acquisition includes the Vectra blood-based test that analyses 12 biomarkers for the measurement of rheumatoid arthritis disease…
04 May 21
Transaction underscores PixCell's leading position in disruptive point-of-care testing technology
04 May 21
FluroTest and TTS will launch and pilot a first-of-its-kind, high-volume Covid-19 testing system from one of the LA-based…
30 Apr 21
The Covid-19 pandemic has underscored the importance of abundant and accurate diagnostics. It will still take quite some…
30 Apr 21
Clinical studies are currently in progress to validate the SARS-CoV-2 antibody test
29 Apr 21
The funding will allow Sera to boost the development of its biomarker tests pipeline to predict major conditions…
29 Apr 21
Test will be made available to physicians and biopharmaceutical companies through Labcorp
29 Apr 21
The Luminostics Clip Analyzer is an analyzer intended to be used for objective readout of cartridge-based immunoluminescent in…
29 Apr 21
AiCE was trained using vast amounts of high-quality image data, and features a deep learning neural network